137 related articles for article (PubMed ID: 4150986)
1. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
Dorris RL; Shore PA
Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
[No Abstract] [Full Text] [Related]
2. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
Zivkovic B; Guidotti A
Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
[No Abstract] [Full Text] [Related]
3. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
Del Rio J; Madroñal J
Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
[TBL] [Abstract][Full Text] [Related]
4. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
Honma T; Fukushima H
Neuropharmacology; 1976 Oct; 15(10):601-7. PubMed ID: 1033478
[No Abstract] [Full Text] [Related]
5. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.
Iversen LL; Rogawski MA; Miller RJ
Mol Pharmacol; 1976 Mar; 12(2):251-62. PubMed ID: 4724
[No Abstract] [Full Text] [Related]
6. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
Burt DR; Creese I; Snyder SH
Science; 1977 Apr; 196(4287):326-8. PubMed ID: 847477
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
[No Abstract] [Full Text] [Related]
8. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
[TBL] [Abstract][Full Text] [Related]
9. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
Van Rossum JM
Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
[No Abstract] [Full Text] [Related]
10. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
11. Dopaminergic neuronal responses to a non-amphetamine CNS stimulant.
German DC; Harden H; Sanghera MK; Mann D; Kiser RS; Miller HH; Shore PA
J Neural Transm; 1979; 44(1-2):39-49. PubMed ID: 35584
[TBL] [Abstract][Full Text] [Related]
12. Short-term control of tyrosine hydroxylase.
Carlsson A; Kehr W; Lindqvist M
Adv Biochem Psychopharmacol; 1974; 12(0):135-42. PubMed ID: 4154020
[No Abstract] [Full Text] [Related]
13. A comparison of CNS stimulants with phencyclidine on dopamine release using in vivo voltammetry.
Howard-Butcher S; Blaha CD; Lane RF
Brain Res Bull; 1984 Oct; 13(4):497-501. PubMed ID: 6151866
[TBL] [Abstract][Full Text] [Related]
14. Effects on hypothalamic self-stimulation of drugs influencing dopaminergic neurotransmission injected into nucleus accumbens and corpus striatum of rats.
Stephens DN; Herberg LJ
Psychopharmacology (Berl); 1977 Aug; 54(1):81-5. PubMed ID: 198840
[TBL] [Abstract][Full Text] [Related]
15. A dopaminergic mechanism mediates the d-amphetamine- and apomorphine-induced increase of ascorbic acid metabolism in the rat striatum.
Miele M; Desole MS; Enrico P; Esposito G; De Natale G; Miele E
Pharmacol Res; 1990; 22 Suppl 3():41-2. PubMed ID: 2097636
[No Abstract] [Full Text] [Related]
16. Dopaminergic substrates of amphetamine-induced place preference conditioning.
Spyraki C; Fibiger HC; Phillips AG
Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
[TBL] [Abstract][Full Text] [Related]
17. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
Puri SK; Reddy C; Lal H
Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
[No Abstract] [Full Text] [Related]
18. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
Bronaugh RL; Tabak J; Ohashi T; Goldstein M
Psychopharmacol Commun; 1975; 1(5):501-10. PubMed ID: 7003
[TBL] [Abstract][Full Text] [Related]
19. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
Vonvoigtlander PF; Losey EG; Triezenberg HJ
J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
Christiansen J; Squires RF
J Pharm Pharmacol; 1974 May; 26(5):367-9. PubMed ID: 4152779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
